Klotho Neurosciences (KLTO) Short Interest Ratio & Short Volume $0.49 +0.04 (+9.02%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Klotho Neurosciences Short Interest DataKlotho Neurosciences (KLTO) has a short interest of 1.11 million shares, representing 4.84% of the float (the number of shares available for trading by the public). This marks a -10.48% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 15.07 million shares to cover all short positions.Current Short Interest1,110,000 sharesPrevious Short Interest1,240,000 sharesChange Vs. Previous Month-10.48%Dollar Volume Sold Short$649.91 thousandShort Interest Ratio0.2 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares70,330,000 sharesFloat Size22,950,000 sharesShort Percent of Float4.84%Today's Trading Volume1,508,140 sharesAverage Trading Volume15,070,354 sharesToday's Volume Vs. Average10% Short Selling Klotho Neurosciences? Sign up to receive the latest short interest report for Klotho Neurosciences and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKLTO Short Interest Over TimeKLTO Days to Cover Over TimeKLTO Percentage of Float Shorted Over Time Klotho Neurosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20251,110,000 shares $649.91 thousand -10.5%4.8%0.2 $0.59 8/31/20251,240,000 shares $860.19 thousand No Change5.4%0 $0.69 KLTO Short Interest - Frequently Asked Questions What is Klotho Neurosciences' current short interest? Short interest is the volume of Klotho Neurosciences shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 1,110,000 shares of KLTO short. 4.84% of Klotho Neurosciences' shares are currently sold short. Learn More on Klotho Neurosciences' current short interest. What is a good short interest percentage for Klotho Neurosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.84% of Klotho Neurosciences' floating shares are currently sold short. Is Klotho Neurosciences' short interest increasing or decreasing? Klotho Neurosciences saw a drop in short interest in September. As of September 15th, there was short interest totaling 1,110,000 shares, a drop of 10.5% from the previous total of 1,240,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Klotho Neurosciences' float size? Klotho Neurosciences currently has issued a total of 70,330,000 shares. Some of Klotho Neurosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Klotho Neurosciences currently has a public float of 22,950,000 shares. How does Klotho Neurosciences' short interest compare to its competitors? 4.84% of Klotho Neurosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Klotho Neurosciences: Lifevantage Corporation (23.34%), Biomea Fusion, Inc. (15.68%), eXoZymes Inc. (0.76%), Inhibikase Therapeutics, Inc. (4.58%), Skye Bioscience, Inc. (15.19%), Kalaris Therapeutics Inc. (10.01%), Fate Therapeutics, Inc. (8.57%), Atossa Genetics Inc. (2.17%), Anixa Biosciences Inc (1.34%), Oramed Pharmaceuticals Inc. (0.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Klotho Neurosciences stock? Short selling KLTO is an investing strategy that aims to generate trading profit from Klotho Neurosciences as its price is falling. KLTO shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Klotho Neurosciences? A short squeeze for Klotho Neurosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KLTO, which in turn drives the price of the stock up even further. How often is Klotho Neurosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KLTO, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies Lifevantage Short Squeeze Biomea Fusion Short Squeeze eXoZymes Short Squeeze Inhibikase Therapeutics Short Squeeze Skye Bioscience Short Squeeze Kalaris Therapeutics Short Squeeze Fate Therapeutics Short Squeeze Atossa Genetics Short Squeeze Anixa Biosciences Short Squeeze Oramed Pharmaceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KLTO) was last updated on 10/3/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Klotho Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Klotho Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.